A report released today showed $50 million in insurance claims for puberty blockers billed using endocrine disorder and nearly $11 million in claims for patients ages 13-17 billed using a diagnosis code for precocious puberty.
A report released today showed $50 million in insurance claims for puberty blockers billed using endocrine disorder and nearly $11 million in claims for patients ages 13-17 billed using a diagnosis code for precocious puberty.